Recent News for GBT - Global Blood Therapeutics, Inc.

Date Title
Jun 22 Global Blood Therapeutics: What The Recent HOPE-KIDS 1 Data Foretells
Jun 21 3 Killer Stocks Trading at Unfair Discounts
Jun 16 Global Blood Therapeutics: Buy Unwarranted Dip Ahead Of HOPE Readout
Jun 15 Mid-Afternoon Market Update: Crude Oil Down Over 3%; Canada Goose Shares Gain Following Strong Q4 Results
Jun 15 Here's Why Shares of Global Blood Therapeutics Inc Are Falling Today
Jun 15 Midday Gainers / Losers (06/15/2018)
Jun 15 Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet
Jun 15 Global Blood Therapeutics Shares Plunge After Sickle Cell Candidate Shows Reduced Effect
Jun 15 Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/15/2018)
Jun 15 Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug
Jun 15 GBT's voxelotor shows lower treatment effect in adolescents with SCD in mid-stage study; shares slip 4% premarket
Jun 15 GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress
Jun 14 Free Technical Reports on Gilead Sciences and Three Additional Biotech Equities
Jun 13 Hematology Conference Could Spur Some of Biotech's Outperformers
Jun 8 GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cell Disease Research’s 12th Annual Symposium
Jun 4 Consolidated Research: 2018 Summary Expectations for ManTech International, Rapid7, Global Blood Therapeutics, CONSOL Coal Resources LP, Ryanair, and Yandex N.V. — Fundamental Analysis, Key Performance Indications
May 30 CRISPR Therapeutics down 20% after hours on IND hold for sickle cell candidate CTX001
May 25 Implied Volatility Surging for Global Blood Therapeutics (GBT) Stock Options
May 25 Global Blood Therapeutics: Elucidating The Upcoming Clinical Binary
May 23 Global Blood Therapeutics: Potential To Enhance Blood Flow In Patients And Money Flow For Investors
May 23 Stocks To Watch: Global Blood Therapeutic Sees RS Rating Jump To 83
May 19 Even Momentum Traders Should Study Stock Charts
May 18 Global Blood Therapeutics Inc’s (NASDAQ:GBT) Profit Outlook
May 17 GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress
May 11 Having Some Good Luck With Biotech Names
Back to the Main GBT Page...